Where were all the armchair quarterbacks when Punit was attending several investor conferences per month (sometimes per week)? Cut the guy some slack. He's doing better than any of the "quarterbacks" could ever do even in their dreams.
From a personal perspective, and I've mentioned this a few times over the past year or so, I don't care if I never make a dime from my investment. The important thing for me is successfully treating patients who are suffering through the horrendous disease called cancer (melanoma, currently, but other forms of cancer, perhaps, in the future) and Punit definitely has the company headed in this direction.
News 
Market Data 
Discover 
